Literature DB >> 23747459

Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience.

Aazim K Omer1, Panayiotis D Ziakas, Theodora Anagnostou, Erin Coughlin, Themistoklis Kourkoumpetis, Steven L McAfee, Bimalangshu R Dey, Eyal Attar, Yi-Bin Chen, Thomas R Spitzer, Eleftherios Mylonakis, Karen K Ballen.   

Abstract

Invasive fungal disease (IFD) is a major cause of morbidity and mortality after hematopoietic stem cell transplantation (HCT). We performed a retrospective review of 271 adults with a hematologic malignancy undergoing allogeneic HCT to determine the incidence of and risk factors for IFD and to examine the impact of IFD on nonrelapse mortality and overall survival. We defined IFD using standard criteria and selected proven and probable cases for analysis. Diagnoses in the study group included acute leukemia (42%), non-Hodgkin lymphoma (24%), myelodysplastic syndrome (15%), chronic lymphocytic leukemia (5%), and other hematologic disorders (14%). Conditioning included reduced-intensity (64%) and myeloablative (36%) regimens. Donor sources were HLA-matched sibling (60%), matched unrelated (20%), haploidentical (12%), and cord blood (8%). A total of 51 episodes of IFD were observed in 42 subjects (15%). Aspergillus spp (47%) was the most frequent causative organism, followed by Candida spp (43%). The majority of IFD cases (67%) were reported after day +100 post-HCT. In multivariate analysis, haploidentical donor transplantation (hazard ratio [HR], 3.82; 95% confidence interval [CI], 1.49-9.77; P = .005) and grade II-IV acute graft-versus-host disease (HR, 2.55; 95% CI, 1.07-6.10; P = .03) were risk factors for the development of IFD. Conversely, higher infused CD34(+) cell dose was associated with a lower risk of IFD (HR, 0.80; 95% CI, 0.68-0.94; P = .006, per 1 × 10(6) cells/kg increase in CD34(+) cell infusion). IFD-related mortality was 33.3%. Nonrelapse mortality was significantly higher in patients who developed IFD compared with those without IFD (P < .001, log-rank test). Patients with IFD had lower overall survival (5.8 months versus 76.1 months; P < .001, log-rank test). Further studies exploring strategies to increase the infused cell dose and determine adequate prophylaxis, especially against aspergillus, beyond day +100 are needed.
Copyright © 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allogeneic hematopoietic stem cell transplantation; CD34(+) cell; Invasive fungal disease

Mesh:

Year:  2013        PMID: 23747459     DOI: 10.1016/j.bbmt.2013.05.018

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  22 in total

1.  PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance.

Authors:  Marios Arvanitis; Panayiotis D Ziakas; Ioannis M Zacharioudakis; Fainareti N Zervou; Angela M Caliendo; Eleftherios Mylonakis
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

2.  Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study.

Authors:  Hua Jin; Zhiping Fan; Fen Huang; Yanyan Chai; Li Xuan; Ren Lin; Na Xu; Jieyu Ye; Jing Sun; Qifa Liu
Journal:  Infection       Date:  2019-02-07       Impact factor: 3.553

3.  How I transplant a patient with a history of invasive fungal disease.

Authors:  Pedro Puerta-Alcalde; Richard Champlin; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2020-08-26       Impact factor: 22.113

4.  Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation.

Authors:  C H Yan; L P Xu; F R Wang; H Chen; W Han; Yu Wang; J Z Wang; K Y Liu; X J Huang
Journal:  Bone Marrow Transplant       Date:  2015-12-21       Impact factor: 5.483

5.  How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal disease.

Authors:  Pedro Puerta-Alcalde; Richard E Champlin; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2020-12-10       Impact factor: 22.113

6.  Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.

Authors:  Marisa H Miceli; Tracey Churay; Thomas Braun; Carol A Kauffman; Daniel R Couriel
Journal:  Mycopathologia       Date:  2017-01-25       Impact factor: 2.574

7.  Clinical and Microbiological Characteristics of Breakthrough Candidemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients in a Japanese Hospital.

Authors:  Muneyoshi Kimura; Hideki Araoka; Hisashi Yamamoto; Yuki Asano-Mori; Shigeki Nakamura; Satoshi Yamagoe; Hideaki Ohno; Yoshitsugu Miyazaki; Masahiro Abe; Mitsuhiro Yuasa; Daisuke Kaji; Kosei Kageyama; Aya Nishida; Kazuya Ishiwata; Shinsuke Takagi; Go Yamamoto; Naoyuki Uchida; Koji Izutsu; Atsushi Wake; Shuichi Taniguchi; Akiko Yoneyama
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 8.  A review of infectious complications after haploidentical hematopoietic stem cell transplantations.

Authors:  Erden Atilla; Pinar Ataca Atilla; Sinem Civriz Bozdağ; Taner Demirer
Journal:  Infection       Date:  2017-04-17       Impact factor: 3.553

9.  Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.

Authors:  Karen Ballen; Kwang Woo Ahn; Min Chen; Hisham Abdel-Azim; Ibrahim Ahmed; Mahmoud Aljurf; Joseph Antin; Ami S Bhatt; Michael Boeckh; George Chen; Christopher Dandoy; Biju George; Mary J Laughlin; Hillard M Lazarus; Margaret L MacMillan; David A Margolis; David I Marks; Maxim Norkin; Joseph Rosenthal; Ayman Saad; Bipin Savani; Harry C Schouten; Jan Storek; Paul Szabolcs; Celalettin Ustun; Michael R Verneris; Edmund K Waller; Daniel J Weisdorf; Kirsten M Williams; John R Wingard; Baldeep Wirk; Tom Wolfs; Jo-Anne H Young; Jeffrey Auletta; Krishna V Komanduri; Caroline Lindemans; Marcie L Riches
Journal:  Biol Blood Marrow Transplant       Date:  2016-06-22       Impact factor: 5.742

10.  Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years.

Authors:  Ji-min Shi; Xu-ying Pei; Yi Luo; Ya-min Tan; Ru-xiu Tie; Jing-song He; Wei-yan Zheng; Jie Zhang; Zhen Cai; Mao-fang Lin; He Huang
Journal:  J Zhejiang Univ Sci B       Date:  2015-09       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.